Inventor
WUN TZE-CHEIN
US24 patents
⚠️ This page may combine multiple inventors who share the name “WUN TZE-CHEIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
9 patentsUS6171587B1Jan 9, 2001
Antibodies to tissue factor inhibitor
SEARLE & CO47 citations95
US6806360B2Oct 19, 2004
Nucleic acids encoding human tissue factor inhibitor
SEARLE & CO23 citations92
US6534276B1Mar 18, 2003
Methods for detecting human tissue factor inhibitor
SEARLE & CO25 citations92
US5648331AJul 15, 1997
Method of inhibiting tissue ischemia and reperfusion injury
SEARLE & CO45 citations87
US5849703ADec 15, 1998
Pre-formed anticoagulant heparin/TFPI complexes
SEARLE & CO15 citations74
US5849875ADec 15, 1998
Human tissue factor inhibitor
SEARLE & CO1 citations62
US5773251AJun 30, 1998
DNA clone of human tissue factor inhibitor
SEARLE & CO2 citations62
US5824660AOct 20, 1998
Method of inhibiting glomerulonephritis
SEARLE & CO4 citations54
US6291427B1Sep 18, 2001
Anticoagulant combination of LACI and sulfated polysaccharides
SEARLE & CO0 citations52
MONSANTO CO
9 patentsUS5466783ANov 14, 1995
Human tissue factor inhibitor
MONSANTO CO38 citations95
US4966852AOct 30, 1990
DNA clone of human tissue factor inhibitor
MONSANTO CO76 citations95
US5212091AMay 18, 1993
Method of producing tissue factor pathway inhibitor
MONSANTO CO71 citations91
US5073626ADec 17, 1991
Affinity purification of plasminogen activator inhibitor I using a modified urokinase
MONSANTO CO6 citations74
US5244676ASep 14, 1993
Modified tissue plasminogen activator with modified glycosylation site
MONSANTO CO2 citations59
US5100666AMar 31, 1992
Modified tissue plasminogen activator K2K2SP
MONSANTO CO2 citations59
US5037752AAug 6, 1991
Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
MONSANTO CO5 citations59
US4963357AOct 16, 1990
Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
MONSANTO CO5 citations59
US5112955AMay 12, 1992
Method of stabilizing plasminogen activator inhibitor by treatment with vitronectin
MONSANTO CO1 citations52
UNIV WASHINGTON
5 patentsUS5914316AJun 22, 1999
Method of inhibiting intimal hyperplasia
UNIV WASHINGTON49 citations92
US5276015AJan 4, 1994
Method of inhibiting microvascular thrombosis
UNIV WASHINGTON41 citations92
US5028534AJul 2, 1991
DNA clones of human placental plasminogen activator inhibitor
UNIV WASHINGTON8 citations70
USRE36476EDec 28, 1999
Method of inhibiting microvascular thrombosis
UNIV WASHINGTON2 citations63
US7060805B2Jun 13, 2006
Methods for isolating tissue factor inhibitor
UNIV WASHINGTON0 citations51